Michael D. Hooven, Director at AtriCure, Inc. (ATRC), sold 71,134 shares at $20.51 ($1.5M) on 2015-03-31, disclosed to the SEC on 2015-04-01.
Scheduled sale ($1.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.01 | 42,500 | $893K | 60.3% |
| 2 | $20.51 | 10,000 | $205K | 13.9% |
| 3 | $20.50 | 18,634 | $382K | 25.8% |
| Total | $20.81 avg | 71,134 | $1.5M | 100% |
| Filing → |
| ATRC | SELL | 2015-01-02 | $577K | — | Filing → |
| ATRC | BUY | 2012-09-17 | $8K | — | Filing → |
| ATRC | BUY | 2012-09-14 | $8K | — | Filing → |